Ofatumumab in multiple sclerosis: 2-year immune profiling and clinical correlates. Esposito A, Corsaro L, Cave ID, Capasso F, et al. J Neurol 2026;273:579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Esposito A, Corsaro L, Cave ID, Capasso F, et al. Ofatumumab in multiple sclerosis: 2-year immune profiling and clinical correlates. J Neurol 2026;273:579.
PMID: 42711594